Authors
Loading...
Targeting METTL3 disrupts transcriptional programs and activates apoptosis and lipid metabolism pathways in AML.
Qian Wang (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: